T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
48 hedge funds and large institutions have $155M invested in T2 Biosystems, Inc in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 4 closing their positions.
80% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 10
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
0% more funds holding
Funds holding: 48 → 48 (0)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
15% less capital invested
Capital invested by funds: $182M → $155M (-$27.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TM
Tiger Management
New York
|
+$6.27M |
| 2 |
LIM
Lagoda Investment Management
New York
|
+$3.16M |
| 3 |
SM
Senvest Management
New York
|
+$3.07M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$948K |
| 5 |
State Street
Boston,
Massachusetts
|
+$767K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.33M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.43M |
| 3 |
PVMCV
Polaris Venture Management Co V
Boston,
Massachusetts
|
-$1.31M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$722K |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$271K |
TTOO Hedge Fund Activity: Q2 2016 in Review
48 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q2 2016, worth a combined $155M — down 15% from $182M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new TTOO positions and 4 closed out — a net gain of 1 holder — while 18 added to existing stakes and 10 trimmed.
The largest buyer was Tiger Management, adding an estimated $6.27M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $3.33M sold.
- 48 institutional investors held T2 Biosystems, Inc (TTOO) as of Q2 2016, unchanged from Q1 2016.
- Funds reported $155M of T2 Biosystems, Inc stock for Q2 2016, down 15% quarter-over-quarter.
- 5 funds opened new T2 Biosystems, Inc positions in Q2 2016 and 4 closed out, a net change of +1 holder.
- The largest T2 Biosystems, Inc buyer in Q2 2016 was Tiger Management, an estimated $6.27M added.
- The largest T2 Biosystems, Inc seller in Q2 2016 was T. Rowe Price Associates, an estimated $3.33M sold.
Based on aggregated 13F filings for Q2 2016.